

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Ko te Adalimumab-aqvh he rongoā koiora e āwhina ana ki te rongoā i ētahi mate ārai-a-tinana mā te whakamārie i tō pūnaha ārai mate e kaha rawa ana. He putanga i hangaia i roto i te taiwhanga o te pūmua tūturu e aukati ana i ngā tohu mumura motuhake i tō tinana, e whakarato ana i te oranga mai i ngā mate pēnei i te rūmātiki, te psoriasis, me te mate whekau mumura.
No te akomanga e kiia nei ko ngā aukati TNF tēnei rongoā, e mahi ana mā te whai i te pūmua tumor necrosis factor-alpha, he pūmua e pā ana ki te mumura me te kino o ngā hononga i te wā e nui ana. Whakaarohia me te mea e whakatakoto ana i te pūwāhi ngawari ki te urupare mumura o tō pūnaha ārai mate.
Ko te Adalimumab-aqvh he putanga koiora o te rongoā adalimumab taketake, ko te tikanga he tata rite tonu te hanganga me te mahi engari i hangaia e tētahi kaihanga rerekē. Ko te wāhanga "aqvh" he kupu tāpiritanga noa e wehe ana i tēnei koiora motuhake mai i ētahi atu i runga i te mākete.
Ko tēnei rongoā werohia i hangaia mai i ngā pūmua i hangaia e whai ana i ngā paturopi tūturu o tō tinana. I hangaia kia tukuna hei werohanga i raro i te kiri, ko te tikanga ka uru ki roto i te kiko momona i raro noa iho i tō kiri, kaua ki roto i te uaua, i te uaua rānei.
Ko ngā koiora pēnei i te adalimumab-aqvh ka pā i ngā whakamātautau kaha kia mōhio ai e mahi ana i te whai huatanga rite tonu ki te rongoā taketake. Ka taea e tō tākuta te whakahau i tēnei kōwhiringa mā te māia, e mōhio ana ka whakarato i ngā painga rongoā rite tonu e hiahia ana koe.
Ka rongoā te Adalimumab-aqvh i ētahi mate ārai-a-tinana e whakaeke hē ana tō pūnaha ārai mate i ngā wāhanga hauora o tō tinana. He tino whai hua te rongoā mō ngā mate e pā ana ki te mumura mau tonu kāore e pai ana ki ngā rongoā tuku iho.
Koinei ngā āhuatanga matua ka taea e tēnei rongoā te āwhina ki te whakahaere:
Ka whakatau tō tākuta mēnā he tika te adalimumab-aqvh mō tō āhuatanga motuhake i runga i ō tohumate, te hītori rongoā, me te pēhea i urupare ai koe ki ētahi atu rongoā. He maha ngā tāngata e kite ana i te whakamaunga nui i te wā kāore anō ētahi atu rongoā i whai mana whakahaere.
Ka mahi a Adalimumab-aqvh mā te aukati i te tumor necrosis factor-alpha (TNF-alpha), he pūmua he tūranga nui ki te whakaputa mumura puta noa i tō tinana. Ki te whai koe i tētahi āhuatanga autoimmune, ka whakaputa tō tinana i te nui rawa o tēnei pūmua, e arahi ana ki ngā tohumate mamae e pā ana ki a koe.
E kiia ana tēnei rongoā he ārai i te pūnaha ārai mate kaha, ko te tikanga ka whakaiti i te mahi o tō pūnaha ārai mate i tētahi huarahi whāinga. Kāore i rite ki ētahi rongoā e whānui ana te aukati i te ārai mate, ka whāinga motuhake te adalimumab-aqvh ki te ara mumura e whakaputa ana i ō tohumate.
Ka tīmata koe ki te kite i ngā whakapainga i roto i te 2-4 wiki i te tīmatanga o te rongoā, ahakoa ka kite ētahi tāngata i ngā huringa i mua atu, i muri mai rānei. Ko te pānga rongoā katoa te nuinga ka whanake i roto i te 3-6 marama i te wā e hanga ana te rongoā i roto i tō pūnaha me te tīmata ki te whakahaere i te mumura.
Ka tukuna a Adalimumab-aqvh hei werohanga i raro i te kiri, ka ako koe ki te tuku i a koe ano ki te kainga i muri i te whakangungu tika mai i to roopu hauora. Ko te nuinga o nga tangata ka werohia ki roto i o ratou huha, puku ranei, me te huri i nga waahi werohanga hei aukati i te riri o te kiri.
He rereke te waarangi horopeta i runga i to ahuatanga, engari ko te nuinga o nga tangata ka whiwhi werohanga ia wiki. Ka timata to taakuta i a koe i runga i te horopeta tika i runga i to tātaritanga motuhake, ka whakatika pea i te wa i runga i te ahua o to urupare.
I mua i ia werohanga, waiho te rongoa kia tae ki te pāmahana rūma mo te 15-30 meneti. Ma tenei ka pai ake te werohanga, ka whakarite kia pai te mahi o te rongoa. Kaore koe e hiahia ki te tango me te kai, ki te karo ranei i te kai i mua i to werohanga.
Whakaorangia to rongoa ki roto i te pouaka whakamātao i waenga i te 36-46°F (2-8°C) ka tiakina mai i te marama. Kaua rawa e whakatio a adalimumab-aqvh, kaua ranei e ruru kaha te ipu, na te mea ka pakaru te hanganga pūmua.
He rereke te roa o te maimoatanga adalimumab-aqvh mai i te tangata ki te tangata, engari ko te nuinga o nga tangata e mate ana i te mate autoimmune e hiahia ana ki te rongoa mo te wa roa ki te pupuri i te mana whakahaere tohu. Ka whakamahi pea etahi tangata mo etahi tau, ko etahi ka hiahia tonu.
Ka aroturuki tonu to taakuta i to urupare ki te maimoatanga, ka whakatika pea i to mahere rongoa i runga i te pai o te whakahaere i o tohu. Mena kei te pai koe, a he pumau to ahuatanga, ka taea e koe te haere tonu i te horopeta kotahi mo nga wa roa.
Ka taea e etahi tangata te whakanui ake i nga werohanga, ka mutu ranei te rongoa mena ka uru to ratou ahuatanga ki te murunga. Heoi, ko te whakamutu wawe ka arahi ki te hokinga mai o nga tohu, no reira he mea nui kia mahi tahi koe me to roopu hauora mo te wa.
He pai te manawanui o te nuinga o te tangata ki te adalimumab-aqvh, engari pērā i ngā rongoā katoa, ka pānga pea ngā pānga taha ki ētahi tāngata. Ko te rongo pai he iti noa iho ngā pānga taha nui, ā, he maha ngā tāngata e pā ana ki ngā tohumate ngawari, e taea ana te whakahaere.
Ngā pānga taha noa ka pā ki a koe:
Ko ngā pānga taha iti noa iho engari nui ake te hiahia kia tere te rongoā. Kei roto i ēnei ngā tohu o te mate nui pērā i te kirika, te wiri, te tohumate pērā i te rewharewha, i te mea ka nui ake te tūponotanga o te mate i te rongoā.
Ngā pānga taha onge engari nui ko ngā tauhohenga mate pāwera nui, ngā raruraru ate, ngā mate toto, ngā take o te pūnaha io. Ka aroturukihia koe e tō tākuta i ngā wā katoa me ngā whakamātautau toto me ngā arowhai kia kitea wawe ngā raruraru pea.
Kāore te Adalimumab-aqvh e tika ana mō te katoa, ina koa mō te hunga e mate ana, e ētahi āhuatanga hauora rānei ka kino ake i te pēhi i te ārai. Ka āta arotakehia e tō tākuta tō hītori hauora i mua i te whakarite i tēnei rongoā.
Kāore koe e tango adalimumab-aqvh mēnā kei a koe:
I tua atu, ko ngā tāngata he pūnaha ārai mate ngoikore, he mate pāwera tawhito, he hunga rānei e tango ana i ētahi atu rongoā ārai mate, tērā pea ka hiahia ki te aroturuki motuhake, ki ētahi atu rongoā rānei. Ka whakataurite tō tākuta i ngā painga ki ngā tūponotanga mō tō āhuatanga motuhake.
Ka hokona te Adalimumab-aqvh i raro i te ingoa waitohu Hyrimoz i te nuinga o ngā whenua. I hangaia tēnei rongoā koiora hei whakarato i tētahi huarahi utu nui ake ki te rongoā adalimumab taketake i te wā e mau tonu ana te whai huatanga rongoā.
Tērā pea ka rongo koe i ngā kaiwhakarato hauora e kōrero ana ki a ia ko te "adalimumab biosimilar" noa iho, i tōna ingoa whānui katoa rānei. Ko te mea nui hei mahara ko te mea ahakoa te ingoa e whakamahia ana, kei te whiwhi koe i te whakauru kaha kotahi kua whakamatauria he whai hua mō tō āhuatanga.
He maha ngā kōwhiringa kei te wātea mēnā kāore te adalimumab-aqvh i te tika mōu, kāore rānei e whakarato i te mana whakahaere tohu e tika ana. Tērā pea ka whakaaro tō tākuta ki ētahi atu aukati TNF, ki ngā rongoā rānei e mahi ana mā ngā huarahi rerekē hei whakahaere i te mumura.
Ko ētahi atu kōwhiringa aukati TNF ko te etanercept, te infliximab, te certolizumab, me te golimumab. He rerekē ngā hōtaka inenga me ngā tikanga whakahaere mō ia mea, nā reira ka taea e tō tākuta te āwhina i a koe ki te kimi i tētahi e pai ana ki tō oranga me ō hiahia hauora.
Ko ngā rongoā koiora kore-TNF pēnei i te rituximab, abatacept, tōcilizumab rānei, e mahi ana mā ngā momo tikanga rerekē, ā, tērā pea e tika ana mēnā kāore ngā aukati TNF e whai hua ana mōu. Ko ngā rongoā rāhuitanga mate-whakawhitiwhiti (DMARDs) pēnei i te methotrexate, e whakamahia whānuitia ana me ngā rongoā koiora, hei whakakapi rānei.
Ko te Adalimumab-aqvh me te Humira (te adalimumab taketake) e kiia ana he rite tonu te whai hua, arā, he rite tonu te pai o tō rāua mahi mō te rongoā i ngā āhuatanga autoimmune. Ka whai wāhi te putanga biosimilar ki ngā whakamātautau whānui hei whakarite kia ōrite te whai huatanga me te haumarutanga o te rongoā taketake.
Ko te painga nui o te adalimumab-aqvh ko te penapena i ngā utu, i te mea he iti ake te utu o ngā biosimilars i ngā rongoā waitohu taketake. Mā tēnei ka māmā ake te rongoā, ka whakaiti i ō whakapaunga i roto i te pūtea, ina koa mehemea e hiahia ana koe ki te rongoā wā-roa.
E mōhio ana ētahi tāngata ki te huri mai i te rongoā taketake ki te biosimilar, engari e whakaatu ana ngā rangahau haumanu ko ngā tāngata e huri ana, ka mau tonu te taumata kotahi o te whakahaere tohu. Ka taea e tō tākuta te āwhina i ngā āwangawanga e pā ana ki te whakawhiti.
Ka taea te whakamahi i te adalimumab-aqvh i roto i ngā tāngata e mate huka ana, engari me mātakitaki pai. Kāore te rongoā e pā tika ana ki ngā taumata huka toto, engari ko ngā mate (e kaha ake ana koe ki te whiwhi i te wā e tango ana koe) ka uaua ake te whakahaere i te mate huka.
Ka mahi tahi tō tākuta me koe kia mōhio ai kei te pai te whakahaere i tō mate huka i te wā e whiwhi ana koe i te rongoā. Mā tēnei pea e whai wāhi ki te mātakitaki i te huka toto i ngā wā maha, me te mahi tahi i waenga i tō rheumatologist me tō endocrinologist.
Mena i te aitua ka werohia e koe he nui ake te adalimumab-aqvh i te mea i tohua, whakapā atu ki tō tākuta, ki tō kaiwhakarato hauora rānei i te wā tonu. Ahakoa kāore he rongoā motuhake mō te nui rawa o te rongoā, me mātakitaki tō tō rōpū hauora i a koe mō te piki ake o te tūponotanga o ngā mate, ētahi atu raruraru rānei.
Kaua e mataku, engari me rapu tohutohu hauora wawe. Ka hiahia pea tō tākuta ki te kite i a koe mō te arotake, ā, ka whakatika pea i tō hōtaka mātakitaki kia mātakitaki mō ngā pānga kino mai i te horopeta nui ake.
Mēnā ka ngaro i a koe tētahi horopeta, tangohia i te wā e mahara ana koe, ka haere tonu ki tō hōtaka auau. Heoi, mēnā kua tata te wā mō tō horopeta e whai ake nei, waiho te horopeta i ngaro, ka haere tonu ki tō hōtaka horopeta auau.
Kaua e rua ngā horopeta hei utu mō te werohanga i ngaro. Engari, whakapā atu ki tō kaiwhakarato hauora mō te ārahi me pēhea te hoki ki te ara me tō hōtaka maimoatanga.
Kaua rawa e whakamutu i te tango adalimumab-aqvh me te kore e kōrero tuatahi ki tō tākuta, ahakoa kei te pai ake koe. Ko te whakamutu ohorere i te maimoatanga ka puta te pikinga o ngā tohu, ā, ka roa pea te wiki, te marama rānei ki te whakahoki i te mana ina tīmata anō koe.
Ka āwhina tō tākuta i a koe ki te whakatau i te wā tika ki te whakaaro ki te whakamutu, ki te whakaiti rānei i tō horopeta i runga i te mana o ō tohu, ngā hua o te mahi toto, me te āhua o tō hauora whānui. Me haere tonu pea ētahi tāngata i te maimoatanga wā-roa kia mau tonu te murunga.
Me karo koe i ngā kano ārai mate ora i te wā e tango ana i te adalimumab-aqvh, nā te mea ka puta pea ngā mate i roto i ngā tāngata he pūnaha ārai mate kua pēhia. Heoi, he haumaru te nuinga o ngā kano ārai mate kore-ora (pēnei i ngā werohanga rewharewha) me te tūtohu.
Kōrero ki tō tākuta mō tō hōtaka kano ārai mate i mua i te tīmatanga o te rongoā. Ka tūtohu pea rātou kia whiwhi koe i ētahi kano ārai mate i mua i tō tīmatanga i te adalimumab-aqvh, ā, ka āwhina rātou i a koe kia noho whakahōuhou tonu mō ngā kano ārai mate haumaru i a koe e whiwhi rongoā ana.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.